61 patents
Page 2 of 4
Utility
IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLS
28 Apr 22
Provided are methods and compositions for obtaining functionally enhanced derivative effector cells obtained from directed differentiation of genomically engineered iPSCs.
Bahram VALAMEHR, Ryan BJORDAHL, Tom Tong LEE
Filed: 25 Nov 19
Utility
Enhanced Stem Cell Composition
21 Apr 22
The invention provides improved methods for cell therapy.
Daniel Shoemaker, David Robbins, John D. Mendlein, Caroline Desponts
Filed: 4 Jun 21
Utility
Reprogramming methods and cell culture platforms
8 Mar 22
The invention provides compositions and methods for manufacturing pluripotent cells.
Bahram Valamehr, Peter Flynn, Ramzey Abujarour, Megan Robinson
Filed: 4 Mar 15
Utility
Methods of Treating Ischemia
24 Feb 22
The invention provides compositions comprising stem and/or progenitor cells that have been treated to enhance the therapeutic properties of the cells for treating ischemia.
Dan Shoemaker, Pratik S. Multani, John D. Mendlein, David Robbins
Filed: 12 Apr 21
Utility
Compositions and Methods for Immune Cell Modulation In Adoptive Immunotherapies
23 Dec 21
Compounds that either produced a higher proportion or greater absolute number of phenotypically identified nave, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified.
Jonathan Rosen, Betsy Rezner, Bahram Valamehr, Ryan Bjordahl, Eigen Peralta
Filed: 7 Jul 21
Utility
Cell Potency Assay for Therapeutic Potential
4 Nov 21
The invention provides cell potency assays for measuring, determining, identifying, confirming, or validating the therapeutic potential of a cell population.
Daniel Shoemaker, David L. Robbins
Filed: 12 Nov 20
Utility
Methods and compositions for inducing hematopoietic cell differentiation
2 Nov 21
The invention provides culture platforms, cell media, and methods of differentiating pluripotent cells into hematopoietic cells.
Bahram Valamehr, Raedun Clarke, Ryan Bjordahl
Filed: 2 Oct 20
Utility
Methods and compositions for inducing hematopoietic cell differentiation
2 Nov 21
The invention provides culture platforms, cell media, and methods of differentiating pluripotent cells into hematopoietic cells.
Bahram Valamehr, Raedun Clarke, Ryan Bjordahl
Filed: 11 Mar 21
Utility
Genomic Engineering of Pluripotent Cells
21 Oct 21
Provided are methods and compositions for obtaining genome-engineered iPSCs, and derivative cells with stable and functional genome editing at selected sites.
Bahram VALAMEHR, Ramzey ABUJAROUR, Tom Tong LEE, Weijie LAN, Raedun CLARKE, Ryan BJORDAHL
Filed: 22 Apr 21
Utility
Stem cell culture media and methods of enhancing cell survival
5 Oct 21
The invention provides improved methods for preparing hematopoietic cells for transplantation and the resulting improved hematopoietic cell compositions.
Betsy Denise Rezner
Filed: 7 Mar 18
Utility
Compositions and methods for immune cell modulation in adoptive immunotherapies
24 Aug 21
Compounds that either produced a higher proportion or greater absolute number of phenotypically identified nave, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified.
Jonathan Rosen, Betsy Rezner, Bahram Valamehr, Ryan Bjordahl, Eigen Peralta
Filed: 20 Jan 17
Utility
Methods and Compositions for Inducing Hematopoietic Cell Differentiation
29 Jul 21
The invention provides culture platforms, cell media, and methods of differentiating pluripotent cells into hematopoietic cells.
Bahram Valamehr, Raedun Clarke, Ryan Bjordahl
Filed: 12 Mar 21
Utility
Genomic engineering of pluripotent cells
27 Jul 21
Provided are methods and compositions for obtaining genome-engineered iPSCs, and derivative cells with stable and functional genome editing at selected sites.
Bahram Valamehr, Ramzey Abujarour, Tom Tong Lee, Weijie Lan, Raedun Clarke, Ryan Bjordahl
Filed: 9 Apr 19
Utility
Methods and Compositions for Inducing Hematopoietic Cell Differentiation
22 Jul 21
The invention provides culture platforms, cell media, and methods of differentiating pluripotent cells into hematopoietic cells.
Bahram Valamehr, Raedun Clarke, Ryan Bjordahl
Filed: 11 Mar 21
Utility
Enhanced stem cell composition
6 Jul 21
The invention provides improved methods for cell therapy.
Daniel Shoemaker, David Robbins, John D. Mendlein, Caroline Desponts
Filed: 12 Dec 18
Utility
Minimal Volume Reprogramming of Mononuclear Cells
1 Jul 21
The invention provides compositions and methods for reprogramming minimal volumes of mononuclear cells.
Peter Flynn, Bahram Valamehr
Filed: 23 Feb 21
Utility
Enhanced Immune Effector Cells and Use Thereof
17 Jun 21
Provided are methods and compositions for obtaining functionally enhanced derivative effector cells obtained from directed differentiation of genomically engineered iPSCs.
Bahram VALAMEHR, Ryan BJORDAHL, Jode GOODRIDGE, Tom Tong LEE
Filed: 19 Feb 21
Utility
Immune Effector Cell Engineering and Use Thereof
3 Jun 21
Provided are methods and compositions for obtaining functionally enhanced derivative effector cells obtained from directed differentiation of genomically engineered iPSCs.
Bahram VALAMEHR, Tom Tong LEE, Ryan BJORDAHL, Jode GOODRIDGE
Filed: 29 Jan 21
Utility
Enhanced Immune Effector Cells and Use Thereof
3 Jun 21
Provided are methods and compositions for obtaining functionally enhanced derivative effector cells obtained from directed differentiation of genomically engineered iPSCs.
Bahram VALAMEHR, Ryan BJORDAHL, Jode GOODRIDGE, Tom Tong LEE
Filed: 11 Jan 21
Utility
Enhanced Immune Effector Cells and Use Thereof
25 Mar 21
Provided are methods and compositions for obtaining functionally enhanced derivative effector cells obtained from directed differentiation of genomically engineered iPSCs.
Bahram VALAMEHR, Ryan BJORDAHL, Jode GOODRIDGE, Tom Tong LEE
Filed: 21 Dec 18